ResearcherZhengzhou UniversityActive in the last 2 years

Yangyang Jia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0004-5641-4357; OpenAlex author ID A5130583168. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine pancreatic cancer. Co-author DOI 10.1136/jitc-2024-010341 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pengju Wang · 1 shared paper, 2025 · strength 0.22
- Paper Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine p… DOI 10.1136/jitc-2024-010341 ↗
Wenyi Yan · 1 shared paper, 2025 · strength 0.22
- Paper Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine p… DOI 10.1136/jitc-2024-010341 ↗
Louisa S. Chard · 1 shared paper, 2025 · strength 0.22
- Paper Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine p… DOI 10.1136/jitc-2024-010341 ↗
Yaohe Wang · 1 shared paper, 2025 · strength 0.22
- Paper Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine p… DOI 10.1136/jitc-2024-010341 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.